Position in DYN
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$33,315,000
-$2,945,000 QoQ
Shares Held
1,500,000
-25.0% QoQ
Ownership
0.803%
of shares outstanding
% of Portfolio
0.51%
of 13F equity value
Holder Rank
#33
of 245 holders
Holding Since
Dec 2021
18 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in DYN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Deep Track Capital, LP holds $5,341,997,223 across 58 Biotechnology names. DYN ranks #37 (0.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | IMVT |
Immunovant, Inc.
|
9,341,151 | $359,914,548 | |
| 2 | GPCR |
Structure Therapeutics Inc.
|
4,740,072 | $254,399,664 | |
| 3 | PCVX |
Vaxcyte, Inc.
|
4,300,000 | $249,959,000 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
825,000 | $248,349,750 | |
| 5 | MANE |
Veradermics, Inc
|
2,000,000 | $245,880,000 | |
| 6 | TARS |
Tarsus Pharmaceuticals, Inc.
|
3,666,768 | $230,786,377 | |
| 7 | OCUL |
Ocular Therapeutix, Inc
|
19,686,282 | $193,319,289 | |
| 8 | BMRN |
Biomarin Pharmaceutical Inc
|
3,307,481 | $189,254,062 |
All Filings in DYN
Export CSV
18 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $33,315,000 | 1,500,000 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $36,260,000 | 2,000,000 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $51,834,000 | 2,650,000 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $25,300,000 | 2,000,000 | Shares | Sole | 2025-11-14 | |
| 2025-03-31 | $20,920,000 | 2,000,000 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $47,120,000 | 2,000,000 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $117,889,440 | 3,282,000 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $141,160,000 | 4,000,000 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $129,327,323 | 4,555,383 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $26,600,000 | 2,000,000 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $21,536,901 | 2,403,672 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $28,124,010 | 2,499,912 | Shares | Sole | 2023-09-06 | |
| 2023-03-31 | $26,894,972 | 2,334,633 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $31,109,878 | 2,684,200 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $40,439,340 | 3,184,200 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $24,045,000 | 3,500,000 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $33,740,000 | 3,500,000 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $27,254,852 | 2,292,250 | Shares | Sole | 2022-02-14 | |
| No filing history on record for this holder in this stock. | ||||||